Correlation Between Teleflex Incorporated and Singular Genomics

Can any of the company-specific risk be diversified away by investing in both Teleflex Incorporated and Singular Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teleflex Incorporated and Singular Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Teleflex Incorporated and Singular Genomics Systems, you can compare the effects of market volatilities on Teleflex Incorporated and Singular Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teleflex Incorporated with a short position of Singular Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teleflex Incorporated and Singular Genomics.

Diversification Opportunities for Teleflex Incorporated and Singular Genomics

-0.7

Correlation Coefficient

Teleflex Incorporated  Singular Genomics

Excellent diversification

The 3 months correlation between Teleflex and Singular is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Teleflex Incorporated and Singular Genomics Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Singular Genomics Systems and Teleflex Incorporated is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teleflex Incorporated are associated (or correlated) with Singular Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Singular Genomics Systems has no effect on the direction of Teleflex Incorporated i.e., Teleflex Incorporated and Singular Genomics go up and down completely randomly.

Pair Corralation between Teleflex Incorporated and Singular Genomics

Considering the 90-day investment horizon Teleflex Incorporated is expected to under-perform the Singular Genomics. But the stock apears to be less risky and, when comparing its historical volatility, Teleflex Incorporated is 4.48 times less risky than Singular Genomics. The stock trades about -0.01 of its potential returns per unit of risk. The Singular Genomics Systems is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  5,940  in Singular Genomics Systems on August 19, 2024 and sell it today you would lose (3,750) from holding Singular Genomics Systems or give up 63.13% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Teleflex Incorporated  vs.  Singular Genomics Systems

Teleflex Incorporated

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Teleflex Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Singular Genomics Systems

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Singular Genomics Systems are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating forward indicators, Singular Genomics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Teleflex Incorporated and Singular Genomics

The main advantage of trading using opposite Teleflex Incorporated and Singular Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teleflex Incorporated position performs unexpectedly, Singular Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Singular Genomics will offset losses from the drop in Singular Genomics' long position.

The idea behind Teleflex Incorporated and Singular Genomics Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.